Presentations & Publications
Novel Early Checkpoint Modifier Demonstrates Broadened and Enhanced CD8+ T Cell Responses Across Multiple Preclinical Studies
05/17/2022
Luber A, et al.
Oral –
ASGCT, Abstract #0490